Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 4
1983 10
1984 4
1985 1
1986 1
1988 1
1989 2
1990 1
1991 3
1992 8
1993 21
1994 14
1995 18
1996 21
1997 27
1998 28
1999 42
2000 39
2001 42
2002 33
2003 59
2004 54
2005 61
2006 59
2007 56
2008 32
2009 38
2010 26
2011 34
2012 16
2013 20
2014 14
2015 9
2016 4
2018 1
2019 1
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

744 results
Results by year
Filters applied: . Clear all
Page 1
Omacetaxine mepesuccinate in chronic myeloid leukemia.
Al Ustwani O, Griffiths EA, Wang ES, Wetzler M. Al Ustwani O, et al. Expert Opin Pharmacother. 2014 Nov;15(16):2397-405. doi: 10.1517/14656566.2014.964642. Expert Opin Pharmacother. 2014. PMID: 25301179 Review.
How we will treat chronic myeloid leukemia in 2016.
Talati C, Ontiveros EP, Griffiths EA, Wang ES, Wetzler M. Talati C, et al. Blood Rev. 2015 Mar;29(2):137-42. doi: 10.1016/j.blre.2014.12.003. Epub 2014 Dec 17. Blood Rev. 2015. PMID: 25555325 Free PMC article. Review.
Naturally occurring antisense RNA.
Dolnick BJ. Dolnick BJ. Pharmacol Ther. 1997 Sep;75(3):179-84. doi: 10.1016/s0163-7258(97)00050-8. Pharmacol Ther. 1997. PMID: 9504138 Review.
Dicer in immune cell development and function.
Devasthanam AS, Tomasi TB. Devasthanam AS, et al. Immunol Invest. 2014;43(2):182-95. doi: 10.3109/08820139.2013.863557. Epub 2013 Dec 4. Immunol Invest. 2014. PMID: 24303839 Free PMC article. Review.
Survivin study: what is the next wave?
Li F. Li F. J Cell Physiol. 2003 Oct;197(1):8-29. doi: 10.1002/jcp.10327. J Cell Physiol. 2003. PMID: 12942537 Review.
744 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page